Therapy

Results: 79398



#Item
41Alabama Board of Examiners in Marriage and Family Therapy Proof of Citizenship (POC) Form – for 2013 MFT License Renewal Instructions: This form is to be completed by existing licensees who are renewing their MFT Licen

Alabama Board of Examiners in Marriage and Family Therapy Proof of Citizenship (POC) Form – for 2013 MFT License Renewal Instructions: This form is to be completed by existing licensees who are renewing their MFT Licen

Add to Reading List

Source URL: www.mft.alabama.gov

Language: English - Date: 2013-10-01 14:47:04
    42STATE OF ALABAMA BOARD OF PHYSICAL THERAPY 100 NORTH UNION STREET, SUITE 724 P.O. BOXMONTGOMERY, ALPhone: (Fax: (

    STATE OF ALABAMA BOARD OF PHYSICAL THERAPY 100 NORTH UNION STREET, SUITE 724 P.O. BOXMONTGOMERY, ALPhone: (Fax: (

    Add to Reading List

    Source URL: pt.alabama.gov

    Language: English - Date: 2017-02-21 15:49:53
      43Menopause Publishes Pivotal Trial Results for Brisdelle™ (Paroxetine) Capsules, an FDA-Approved Non-Hormonal Therapy for Vasomotor Symptoms Associated with Menopause Miami, FL and New York, NY, September 18, 2013 – N

      Menopause Publishes Pivotal Trial Results for Brisdelle™ (Paroxetine) Capsules, an FDA-Approved Non-Hormonal Therapy for Vasomotor Symptoms Associated with Menopause Miami, FL and New York, NY, September 18, 2013 – N

      Add to Reading List

      Source URL: www.noven.com

      Language: English - Date: 2013-09-18 09:10:14
        44CLIENT BULLETIN Measuring Buprenorphine and Norbuprenorphine in Urine Buprenorphine is used as a replacement therapy in the treatment of opioid dependence and as an analgesic. This medication also has the potential for

        CLIENT BULLETIN Measuring Buprenorphine and Norbuprenorphine in Urine Buprenorphine is used as a replacement therapy in the treatment of opioid dependence and as an analgesic. This medication also has the potential for

        Add to Reading List

        Source URL: www.pactox.com

        Language: English - Date: 2017-07-10 14:23:26
          45NOVEN REPORTS POSITIVE PHASE 2 RESULTS FOR MESAFEM™ NON-HORMONAL THERAPY FOR VASOMOTOR SYMPTOMS Miami, FL – July 14, 2009 – Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) today announced positive top-line results from

          NOVEN REPORTS POSITIVE PHASE 2 RESULTS FOR MESAFEM™ NON-HORMONAL THERAPY FOR VASOMOTOR SYMPTOMS Miami, FL – July 14, 2009 – Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) today announced positive top-line results from

          Add to Reading List

          Source URL: www.noven.com

          Language: English - Date: 2013-06-27 13:50:45
            46Meeting Minutes September 29, 2009 The Alabama Board of Examiners in Marriage and Family Therapy met on September 29, 2009, at 9:00 a.m. in Montgomery, Alabama at a special called meeting for the purpose of reviewing bid

            Meeting Minutes September 29, 2009 The Alabama Board of Examiners in Marriage and Family Therapy met on September 29, 2009, at 9:00 a.m. in Montgomery, Alabama at a special called meeting for the purpose of reviewing bid

            Add to Reading List

            Source URL: mft.alabama.gov

            Language: English - Date: 2012-10-30 08:18:27
              478 gennaio 2017 EFTA CLINIC INTERVENTIONS IN FAMILY THERAPY, N°4, SPRINGER, BERLIN (EDITOR JUAN LUIS LINARES AND ROBERTO PEREIRA) A

              8 gennaio 2017 EFTA CLINIC INTERVENTIONS IN FAMILY THERAPY, N°4, SPRINGER, BERLIN (EDITOR JUAN LUIS LINARES AND ROBERTO PEREIRA) A

              Add to Reading List

              Source URL: www.scuolamaraselvini.it

              Language: Italian - Date: 2017-05-12 10:15:18
                48THERAPY TODAY 34 FEBRUARY 2018

                THERAPY TODAY 34 FEBRUARY 2018

                Add to Reading List

                Source URL: cliniq.org.uk

                Language: English - Date: 2018-04-30 19:18:57
                  49CDKL5 Program of Excellence Pilot Grant Program Application Title: Development of TALE and CRISPR/Cas9 as a putative therapy for treatment or correction of genetically linked CDKL5 Deficiency PI: Jan Nolta, PhD Instituti

                  CDKL5 Program of Excellence Pilot Grant Program Application Title: Development of TALE and CRISPR/Cas9 as a putative therapy for treatment or correction of genetically linked CDKL5 Deficiency PI: Jan Nolta, PhD Instituti

                  Add to Reading List

                  Source URL: www.louloufoundation.org

                  Language: English - Date: 2017-01-08 10:42:07
                    508-4 Scientific Investigation of the Basis of Particle Therapy -Biophysical ApproachSession Organizers: Koji Tsuboi, Kenta Takada Sep 27 (Wed)

                    8-4 Scientific Investigation of the Basis of Particle Therapy -Biophysical ApproachSession Organizers: Koji Tsuboi, Kenta Takada Sep 27 (Wed)

                    Add to Reading List

                    Source URL: www.kokuren.tsukuba.ac.jp

                    Language: English - Date: 2017-09-05 04:17:49